학술논문

Regulatory claims made by US businesses engaged in direct-to-consumer marketing of purported stem cell treatments and exosome therapies
Document Type
Article
Source
In: Regenerative Medicine. (Regenerative Medicine, 1 November 2023, 18(11):857-868)
Subject
Language
English
ISSN
1746076X
17460751